Safety and immunogenicity of SARS-CoV-2 protein subunit recombinant vaccine (Indovac®) in healthy populations aged 18 years and above in Indonesia: A phase I, observer-blind, randomized, controlled study
在印度尼西亚18岁及以上健康人群中,SARS-CoV-2蛋白亚单位重组疫苗(Indovac®)的安全性和免疫原性:一项I期、观察者盲法、随机、对照研究
期刊:Human Vaccines & Immunotherapeutics
影响因子:3.5
doi:10.1080/21645515.2025.2501467
Nency, Yetty Movieta; Sekartini, Rini; Wirahmadi, Angga; Maria, Suzy; Farhanah, Nur; Hapsari, Rebriarina; Mahati, Endang; Maharani, Nani; Mulyono, Mulyono; Anantyo, Dimas Tri; Pramudo, Setyo Gundi; Yeremia, Glenn Fernandez; Setyaningsih, Lilis; Puspita, Mita; Sari, Rini Mulia